Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The pharmacology of latent inhibition as an animal model of schizophrenia
Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study
Its primary pharmacological characterization was published in European Journal of Endocrinology (PMID 9849822), where the authors identified it as the first growth-hormone-secretagogue receptor (GHSR-1a) agonist achieving GH-release selectivity comparable to GHRH in animal models
His approach, while personalized through medical supervision, follows principles applicable to anyone
US$ 21.20
US$ 25.07
US$ 20.52
US$ 26.49
